Yusuke Nakamura to Injections, Intravenous
This is a "connection" page, showing publications Yusuke Nakamura has written about Injections, Intravenous.
Connection Strength
0.027
-
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget. 2012 Dec; 3(12):1629-40.
Score: 0.027